Ligand Pharmaceuticals (LGND) insider buying
6 open-market purchases of LGND by Ligand Pharmaceuticals's executives and directors since January 2026, worth $0 in total, from SEC Form 4 filings.
The most recent: Gilbert Ray Cisneros, Jr. bought — on March 3, 2026.
The biggest buyer over the period is Gilbert Ray Cisneros, Jr.: 6 purchases, $0.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 6 | $0 |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Gilbert Ray Cisneros, Jr. | 6 | $0 |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Mar 3, 2026 | Gilbert Ray Cisneros, Jr. |
0 | $204.24 | — | — |
| Mar 3, 2026 | Gilbert Ray Cisneros, Jr. |
0 | $204.24 | — | — |
| Jan 15, 2026 | Gilbert Ray Cisneros, Jr. |
0 | $196.08 | — | — |
| Jan 15, 2026 | Gilbert Ray Cisneros, Jr. |
0 | $196.08 | — | — |
| Jan 5, 2026 | Gilbert Ray Cisneros, Jr. |
0 | $192.03 | — | — |
| Jan 5, 2026 | Gilbert Ray Cisneros, Jr. |
0 | $192.03 | — | — |
Questions
Are Ligand Pharmaceuticals insiders buying the stock?
6 open-market purchases of LGND by Ligand Pharmaceuticals's executives and directors since January 2026, worth $0 in total, from SEC Form 4 filings. The most recent: Gilbert Ray Cisneros, Jr. bought — on March 3, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From Ligand Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.